Inquiry
Cyclophosphamide Tablet
Product Details:
- Application Other
- Storage Instructions Keep at cool and dry place
X
Product Specifications
- Keep at cool and dry place
- Other
Trade Information
- Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Asia
- All India
Product Description
Cyclophosphamide Tablet has been prescribed for treatment of leukemia, multiple myeloma, breast & ovarian cancer, and sarcoma. It is a chemotherapy medicine that can also be used for suppressing immune system of body for various purposes. This tablet is known to form metabolite phosphoramide mustard in cells having low ALDH levels and forms DNA crosslinks resulting in apoptosis. Active chemical used in its formulation has molecular formula C7H15Cl2N2O2P with molar mass of 261.086 g/mol. Cyclophosphamide Tablet has bioavailability of around 75% with protein binding ability of more than 60% and metabolism in liver. It gets excreted from kidney having elimination half life of 3-12 hours.Product Details:
- Minimum Order Quantity : 50 Box
- Category : Breast Cancer, Lung Cancer
- Certification : ISO 9001:2008, FDA, GMP
- Dosage Form : Oral
- Dose : 50 mg
- Type : Allopathic
Uses
Cyclophosphamide is used in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer and blood cancer
How it works
Cyclophosphamide works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
Common side effects
Rash, Reduced blood platelets, Headache, Dizziness, Convulsion, Myelosuppression, Coordination disorder.
Enter Buying Requirement Details
Other Products in 'Anticancer Drugs' category
We deal in bulk foreign inquiries.
Get In Touch
ACTIZA PHARMACEUTICAL PRIVATE LIMITED
- 309, Royal Square, Utaran, Surat - 394105, Gujarat, India
- Phone :08037301453
- Mr Milan Sojitra (BDM)
- Mobile :08037301453
-
Send Inquiry
Send Inquiry
Send Inquiry
Send SMS
|
 |
ACTIZA PHARMACEUTICAL
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |